AGAR Surveillance Outcome Programs 2023 Report
This report provides analyses of Australian Group on Antimicrobial Resistance (AGAR) data on bloodstream infections in enterococcal species, Staphylococcus aureus and gram-negative bacteria across Australia in 2023. The report also includes considerations and implications for patient safety and delivery of care.
Released December 2024
Accessibility - We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Copyright - Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-No Derivatives (BY-NC-ND) 4.0 International License.
Request permission to reproduce material produced by the Commission by completing this form.